People on the Move Archives - Page 134 of 144

Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Expanding Clinical Data Capabilities to Accelerate Drug Development

October 29, 2025

Boston IVF Chief Scientific Officer Denny Sakkas, PhD Receives Prestigious 2025 ASRM Distinguished Researcher Award for Lifetime Contributions to Fertility Research

October 27, 2025

Alloy Therapeutics Announces Acquisition of Spannerwerks, a Leading Provider of Drug Development Consulting Services

October 23, 2025

THIS WEEK'S STORIES

Insulet Launches Global Initiative to Advance Workplace Inclusion for People with Diabetes

October 30, 2025

Stigma, Not Condition, Is the Biggest Barrier for 1 in 3 People Living With Chronic Conditions, Convatec Study Finds

October 27, 2025

MOPIC Unveils 32-Inch Autostereoscopic 3D Display for Medical Imaging and Training

October 29, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

Tiugo Technologies Names Andrew Iappini as Chief Financial Officer

Montai Therapeutics Names Hans Hull as Chief Operations Officer

CareDx Appoints Jeffrey John Teuteberg, MD as Chief Medical Officer

Provation Appoints Dr. Lukasz Kowalczyk as Executive Medical Director to Drive Provider-Focused Innovation and AI Leadership

Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman

Most Read

InterVene Receives FDA Clearance for Recana, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions

Manhattan Genomics Assembles World-Class Scientific Team to Lead a New Era of Genomic Medicine

Gut Neurons Decoded: New Study Reveals How Food Allergies and Microbes Rewire the Gut’s Nervous System

Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis

EDITOR PICKS